Compare $ALGN vs $MDLN | Chartloom

Compare

$ALGN vs $MDLN

Align Technology Inc · Medline Inc

ALGN

Align Technology Inc

MDLN

Medline Inc

Compare $ALGN vs $MDLN

Comparing Align Technology Inc and Medline Inc

ALGNAlign Technology Inc

MDLNMedline Inc

ALGNAlign Technology Inc

Market cap

$10.22B

P/E (TTM)

24.68x

Forward P/E (NTM)

11.84x

Forward P/S (NTM)

2.37x

Rev growth (TTM)

4.4%

YTD performance

-8.5%

52W performance

7.2%

FCF yield

6.2%

MDLNMedline Inc

Market cap

$47.63B

P/E (TTM)

44.92x

Forward P/E (NTM)

24.12x

Forward P/S (NTM)

1.44x

Rev growth (TTM)

—

YTD performance

-10.7%

52W performance

-11.6%

FCF yield

3.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ALGN

MDLN

Detailed metrics comparison

ALGN

Align Technology Inc

MDLN

Medline Inc

Market Cap

ALGN$10.22B

MDLN$47.63B

Enterprise Value

ALGN$9.13B

MDLN$57.88B

Price

ALGN$142.71

MDLN$36.26

P/E Ratio

ALGN24.68x

MDLN44.92x

P/S Ratio

ALGN2.47x

MDLN1.59x

EV/Sales

ALGN2.21x

MDLN1.93x

EV/EBITDA

ALGN9.61x

MDLN17.66x

P/B Ratio

ALGN2.41x

MDLN4.05x

P/FCF Ratio

ALGN16.13x

MDLN30.81x

EV/FCF

ALGN14.42x

MDLN37.44x

PEG Ratio

ALGN2.88x

MDLN3.82x

Forward P/E (NTM)

ALGN11.84x

MDLN24.12x

Forward P/S (NTM)

ALGN2.37x

MDLN1.44x

Revenue (TTM)

ALGN$4.14B

MDLN$29.94B

Revenue Growth (YoY)

ALGN4.4%

MDLNN/A

Forward Rev Growth

ALGN4.1%

MDLN7.8%

Gross Margin (TTM)

ALGN69.0%

MDLN26.2%

Operating Margin (TTM)

ALGN13.2%

MDLN6.0%

EBITDA Margin (TTM)

ALGN22.9%

MDLN10.9%

Net Margin (TTM)

ALGN10.0%

MDLN2.3%

FCF Margin (TTM)

ALGN15.3%

MDLN5.2%

Net Income (TTM)

ALGN$414M

MDLN$695M

FCF (TTM)

ALGN$634M

MDLN$1.55B

EPS (TTM)

ALGN$5.78

MDLN$0.81

ROE (TTM)

ALGN10.1%

MDLN5.5%

ROA (TTM)

ALGN6.6%

MDLN1.8%

ROIC (TTM)

ALGN10.1%

MDLN2.6%

Cash

ALGN$1.09B

MDLN$2.33B

Debt

ALGN$0

MDLN$12.58B

Net Cash/Debt

ALGN$1.09B

MDLN$-10.25B

Current Ratio (TTM)

ALGN1.40x

MDLN4.33x

Quick Ratio (TTM)

ALGN1.23x

MDLN2.61x

Debt/Equity (TTM)

ALGN0.00x

MDLN1.09x

Debt/Assets (TTM)

ALGN0.0%

MDLN0.0%

Interest Coverage (TTM)

ALGNN/A

MDLNN/A

Net Debt/EBITDA (TTM)

ALGN0.00x

MDLN0.00x

Beta

ALGN1.74

MDLN0.94

52W Performance

ALGN7.2%

MDLN-11.6%

YTD Performance

ALGN-8.5%

MDLN-10.7%

% from 52W High

ALGN-28.8%

MDLN-28.7%

% from 52W Low

ALGN14.3%

MDLN15.1%

Asset Turnover (TTM)

ALGN0.66x

MDLN0.78x

FCF Yield (TTM)

ALGN6.2%

MDLN3.2%

Earnings Yield (TTM)

ALGN4.0%

MDLN1.5%

Dividend Yield (TTM)

ALGNN/A

MDLNN/A

Rule of 40

ALGN19.7

MDLN5.2

EV/GP/RG

ALGN0.79

MDLN0.72

Ticker research

View ALGN research View MDLN research

Metric	ALGN Align Technology Inc	MDLN Medline Inc
Market & Valuation
Market Cap	$10.22B	$47.63B
Enterprise Value	$9.13B	$57.88B
Price	$142.71	$36.26
P/E Ratio	24.68x	44.92x
P/S Ratio	2.47x	1.59x
EV/Sales	2.21x	1.93x
EV/EBITDA	9.61x	17.66x
P/B Ratio	2.41x	4.05x
P/FCF Ratio	16.13x	30.81x
EV/FCF	14.42x	37.44x
PEG Ratio	2.88x	3.82x
Forward P/E (NTM)	11.84x	24.12x
Forward P/S (NTM)	2.37x	1.44x
Revenue & Growth
Revenue (TTM)	$4.14B	$29.94B
Revenue Growth (YoY)	4.4%	N/A
Forward Rev Growth	4.1%	7.8%
Profitability
Gross Margin (TTM)	69.0%	26.2%
Operating Margin (TTM)	13.2%	6.0%
EBITDA Margin (TTM)	22.9%	10.9%
Net Margin (TTM)	10.0%	2.3%
FCF Margin (TTM)	15.3%	5.2%
Net Income (TTM)	$414M	$695M
FCF (TTM)	$634M	$1.55B
EPS (TTM)	$5.78	$0.81
ROE (TTM)	10.1%	5.5%
ROA (TTM)	6.6%	1.8%
ROIC (TTM)	10.1%	2.6%
Financial Health
Cash	$1.09B	$2.33B
Debt	$0	$12.58B
Net Cash/Debt	$1.09B	$-10.25B
Current Ratio (TTM)	1.40x	4.33x
Quick Ratio (TTM)	1.23x	2.61x
Debt/Equity (TTM)	0.00x	1.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.74	0.94
52W Performance	7.2%	-11.6%
YTD Performance	-8.5%	-10.7%
% from 52W High	-28.8%	-28.7%
% from 52W Low	14.3%	15.1%
Efficiency & Yields
Asset Turnover (TTM)	0.66x	0.78x
FCF Yield (TTM)	6.2%	3.2%
Earnings Yield (TTM)	4.0%	1.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	19.7	5.2
EV/GP/RG	0.79	0.72
Ticker research	View ALGN research	View MDLN research

Valuation

P/E Ratio

ALGN

24.68x

MDLN

44.92x

P/S Ratio

MDLN

1.59x

ALGN

2.47x

EV/FCF

ALGN

14.42x

MDLN

37.44x

Growth & revenue

Revenue Growth TTM

ALGN

4.4%

Forward Revenue Growth

MDLN

7.8%

ALGN

4.1%

Profitability & performance

Gross Margin

ALGN

69.0%

MDLN

26.2%

ROE

ALGN

10.1%

MDLN

5.5%

FCF Yield %

ALGN

6.2%

MDLN

3.2%

52-Week Performance

ALGN

7.2%

MDLN

-11.6%

Detailed metrics comparison

ALGN

Align Technology Inc

MDLN

Medline Inc

Market Cap

ALGN$10.22B

MDLN$47.63B

Enterprise Value

ALGN$9.13B

MDLN$57.88B

Price

ALGN$142.71

MDLN$36.26

P/E Ratio

ALGN24.68x

MDLN44.92x

P/S Ratio

ALGN2.47x

MDLN1.59x

EV/Sales

ALGN2.21x

MDLN1.93x

EV/EBITDA

ALGN9.61x

MDLN17.66x

P/B Ratio

ALGN2.41x

MDLN4.05x

P/FCF Ratio

ALGN16.13x

MDLN30.81x

EV/FCF

ALGN14.42x

MDLN37.44x

PEG Ratio

ALGN2.88x

MDLN3.82x

Forward P/E (NTM)

ALGN11.84x

MDLN24.12x

Forward P/S (NTM)

ALGN2.37x

MDLN1.44x

Revenue (TTM)

ALGN$4.14B

MDLN$29.94B

Revenue Growth (YoY)

ALGN4.4%

MDLNN/A

Forward Rev Growth

ALGN4.1%

MDLN7.8%

Gross Margin (TTM)

ALGN69.0%

MDLN26.2%

Operating Margin (TTM)

ALGN13.2%

MDLN6.0%

EBITDA Margin (TTM)

ALGN22.9%

MDLN10.9%

Net Margin (TTM)

ALGN10.0%

MDLN2.3%

FCF Margin (TTM)

ALGN15.3%

MDLN5.2%

Net Income (TTM)

ALGN$414M

MDLN$695M

FCF (TTM)

ALGN$634M

MDLN$1.55B

EPS (TTM)

ALGN$5.78

MDLN$0.81

ROE (TTM)

ALGN10.1%

MDLN5.5%

ROA (TTM)

ALGN6.6%

MDLN1.8%

ROIC (TTM)

ALGN10.1%

MDLN2.6%

Cash

ALGN$1.09B

MDLN$2.33B

Debt

ALGN$0

MDLN$12.58B

Net Cash/Debt

ALGN$1.09B

MDLN$-10.25B

Current Ratio (TTM)

ALGN1.40x

MDLN4.33x

Quick Ratio (TTM)

ALGN1.23x

MDLN2.61x

Debt/Equity (TTM)

ALGN0.00x

MDLN1.09x

Debt/Assets (TTM)

ALGN0.0%

MDLN0.0%

Interest Coverage (TTM)

ALGNN/A

MDLNN/A

Net Debt/EBITDA (TTM)

ALGN0.00x

MDLN0.00x

Beta

ALGN1.74

MDLN0.94

52W Performance

ALGN7.2%

MDLN-11.6%

YTD Performance

ALGN-8.5%

MDLN-10.7%

% from 52W High

ALGN-28.8%

MDLN-28.7%

% from 52W Low

ALGN14.3%

MDLN15.1%

Asset Turnover (TTM)

ALGN0.66x

MDLN0.78x

FCF Yield (TTM)

ALGN6.2%

MDLN3.2%

Earnings Yield (TTM)

ALGN4.0%

MDLN1.5%

Dividend Yield (TTM)

ALGNN/A

MDLNN/A

Rule of 40

ALGN19.7

MDLN5.2

EV/GP/RG

ALGN0.79

MDLN0.72

Ticker research

View ALGN research View MDLN research

Metric	ALGN Align Technology Inc	MDLN Medline Inc
Market & Valuation
Market Cap	$10.22B	$47.63B
Enterprise Value	$9.13B	$57.88B
Price	$142.71	$36.26
P/E Ratio	24.68x	44.92x
P/S Ratio	2.47x	1.59x
EV/Sales	2.21x	1.93x
EV/EBITDA	9.61x	17.66x
P/B Ratio	2.41x	4.05x
P/FCF Ratio	16.13x	30.81x
EV/FCF	14.42x	37.44x
PEG Ratio	2.88x	3.82x
Forward P/E (NTM)	11.84x	24.12x
Forward P/S (NTM)	2.37x	1.44x
Revenue & Growth
Revenue (TTM)	$4.14B	$29.94B
Revenue Growth (YoY)	4.4%	N/A
Forward Rev Growth	4.1%	7.8%
Profitability
Gross Margin (TTM)	69.0%	26.2%
Operating Margin (TTM)	13.2%	6.0%
EBITDA Margin (TTM)	22.9%	10.9%
Net Margin (TTM)	10.0%	2.3%
FCF Margin (TTM)	15.3%	5.2%
Net Income (TTM)	$414M	$695M
FCF (TTM)	$634M	$1.55B
EPS (TTM)	$5.78	$0.81
ROE (TTM)	10.1%	5.5%
ROA (TTM)	6.6%	1.8%
ROIC (TTM)	10.1%	2.6%
Financial Health
Cash	$1.09B	$2.33B
Debt	$0	$12.58B
Net Cash/Debt	$1.09B	$-10.25B
Current Ratio (TTM)	1.40x	4.33x
Quick Ratio (TTM)	1.23x	2.61x
Debt/Equity (TTM)	0.00x	1.09x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.74	0.94
52W Performance	7.2%	-11.6%
YTD Performance	-8.5%	-10.7%
% from 52W High	-28.8%	-28.7%
% from 52W Low	14.3%	15.1%
Efficiency & Yields
Asset Turnover (TTM)	0.66x	0.78x
FCF Yield (TTM)	6.2%	3.2%
Earnings Yield (TTM)	4.0%	1.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	19.7	5.2
EV/GP/RG	0.79	0.72
Ticker research	View ALGN research	View MDLN research